3Marra CA, MalTa F, Cox VC, et al. Factors influencing quality of Life in patients with active tuberculosis[J].Health Qual Life Outcomes, 2012, 2 (2): 58-62.
4Driver CR, Munsiff SS, Li J, et al. Relapsein persons treated for Drug- susceptible tuberculosis in a population with high eoinfeetion will human immunodeficiency virus in New York City [J]. Clin Infect Dis, 2011, 33 (10) : 1762-1769.
5Benator D, Bhattacharya M, Bozeman L, et al. Rifapentine and ionized once awake versus rifampicin and ionized twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV- negative patients: a randomized clinical trial[J]. Lancet, 2012, 360 (9332) : 528-534.
6Shaikh MA, Singla R, Khan NB, et al. Does diabetes alter the radiologi- cal presentation of pulmonary tuberculosis[J]. Saudi Med J, 2013, 24 (3) : 278-281.
7Bashar M, Alcabes P, Rom WN, et al. Increased incidence of multidrug resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987to1997 [J]. Chest, 2011, 120 (5): 1514-1519.
8Murray J, Sonnenburg P, Shearer SC, et al. Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tu- berculosis in African patients[J]. Am J Respir Crit Care, 2013, 159 (3) : 733-740.
